Sapuppo A, Pavone P, Praticò AD, Ruggieri M, Bertino G, Fiumara A (2020) Genotype-phenotype variable correlation in Wilson disease: clinical history of two sisters with the similar genotype. BMC Med Genet 21(1):128

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kulkarni A, Sharma VK (2016) Wilson’s disease. In: Quah SR (ed) International encyclopedia of public health, vol 369. Elsevier, Amsterdam, pp 424–433

Google Scholar 

Poujois A, Woimant F, Samson S, Chaine P, Girardot-Tinant N, Tuppin P (2018) Characteristics and prevalence of Wilson’s disease: a 2013 observational population-based study in France. Clin Res Hepatol Gastroenterol 42(1):57–63

Article  PubMed  Google Scholar 

Collet C, Laplanche JL, Page J, Morel H, Woimant F, Poujois A (2018) High genetic carrier frequency of Wilson’s disease in France: discrepancies with clinical prevalence. BMC Med Genet 19(1):143

Article  PubMed  PubMed Central  Google Scholar 

Jang JH, Lee T, Bang S, Kim YE, Cho EH (2017) Carrier frequency of Wilson’s disease in the Korean population: a DNA-based approach. J Hum Genet 62(9):815–818

Article  CAS  PubMed  Google Scholar 

Mulligan C, Bronstein JM (2020) Wilson disease: an overview and approach to management. Neurol Clin 38(2):417–432

Article  PubMed  Google Scholar 

Tarnacka B, Jopowicz A, Maślińska M (2021) Copper, iron, and manganese toxicity in neuropsychiatric conditions. Int J Mol Sci 22(15):7820

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kalita J, Kumar V, Misra UK, Parashar V, Ranjan A (2020) Adjunctive antioxidant therapy in neurologic Wilson’s disease improves the outcomes. J Mol Neurosci MN. 70:378–385

Article  CAS  PubMed  Google Scholar 

Machado A, Chien HF, Deguti MM, Cancado E, Azevedo RS, Scaff M, Barbosa ER (2006) Neurological manifestations in Wilson’s disease: report of 119 cases. Mov Disord 21:2192–2196

Article  PubMed  Google Scholar 

Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR (2007) Wilson disease: description of 282 patients evaluated over 3 decades. Medicine 86:112–121

Article  PubMed  Google Scholar 

Kalita J, Misra UK, Kumar V, Parashar V (2019) Predictors of seizure in Wilson disease: a clinico-radiological and biomarkers study. Neurotoxicology 71:87–92

Article  PubMed  Google Scholar 

Litwin T, Gromadzka G, Czlonkowska A, Golebiowski M, Poniatowska R (2013) The effect of gender on brain MRI pathology in Wilson’s disease. Metab Brain Dis 28:69–75

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sinha S, Taly AB, Prashanth LK, Ravishankar S, Arunodaya GR, Vasudev MK (2007) Sequential MRI changes in Wilson’s disease with de-coppering therapy: a study of 50 patients. Br J Radiol 80(957):744–749

Article  CAS  PubMed  Google Scholar 

Patel N, Jankovic J, Hallett M (2014) Sensory aspects of movement disorders. Lancet Neurol 3(1):100–112

Article  Google Scholar 

Karimi M, Moerlein SM, Videen TO, Luedtke RR, Taylor M, Mach RH, Perlmutter JS (2011) Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect? Mov Disord 26(1):100–106

Article  PubMed  Google Scholar 

Lutsenko S, Washington-Hughes C, Ralle M, Schmidt K (2019) Copper and the brain oradrenergic system. J Biol Inorg Chem 24(8):1179–1188

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roberts EA, Schilsky ML (2008) Diagnosis and treatment of Wilson disease: an update. Hepatology 47(6):2089–2111

Article  CAS  PubMed  Google Scholar 

Krystkowiak P, du Montcel ST, Vercueil L, Houeto JL, Lagrange C, Cornu P, Blond S, Benabid AL, Pollak P, Vidailhet M, SPIDY Group (2007) Reliability of the Burke-Fahn-Marsden scale in a multicenter trial for dystonia. Mov Dis 22(5):685–689

Article  Google Scholar 

Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28(07):863–873

Article  PubMed  PubMed Central  Google Scholar 

Grimm G, Prayer L, Oder W, Ferenci P, Madl C, Knoflach P, Schneider B, Imhof H, Gangl A (1991) Comparison of functional and structural brain disturbances in Wilson’s disease. Neurology. 41(2 (Pt 1)):272–6

Article  CAS  PubMed  Google Scholar 

Nijeholt JLÀ, Korf J (1978) Wilson’s disease and monoamines. Arch Neurol 35(9):617–618

Article  CAS  PubMed  Google Scholar 

Kalita J, Naik S, Bhoi SK, Misra UK, Ranjan A, Kumar S (2017) Pontomesencephalic atrophy and postural instability in Wilson disease. AJNR Am J Neuroradiol 38:1343–1347

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anden NE, Carlsson A, Dahlstroem A, Fuxe K, Hillarp NA, Larsson K (1964) Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sci 3:523–530

Article  CAS  Google Scholar 

Narayanan NS, Guarnieri DJ, DiLeone RJ (2010) Metabolic hormones, dopamine circuits, and feeding. Front Neuroendocrinol 31(1):104–112

Article  CAS  PubMed  Google Scholar 

Gerfen CR, Herkenham M, Thibault J (1987) The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci 7:3915–3934

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lindvall O, Björklund A, Skagerberg G (1984) Selective histochemical demonstration of dopamine terminal systems in rat di- and telencephalon: new evidence for dopaminergic innervation of hypothalamic neurosecretory nuclei. Brain Res 306:19–30

Article  CAS  PubMed  Google Scholar 

Zhai S, Tanimura A, Graves SM, Shen W, Surmeier DJ (2018) Striatal synapses, circuits, and Parkinson’s disease. Curr Opin Neurobiol 48:9–16

Article  CAS  PubMed  Google Scholar 

Zuber SM, Kantorovich V, Pacak K (2011) Hypertension in pheochromocytoma: characteristics and treatment. Endocrinol Metab Clin North Am 40(2):295–311

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greco AV, Ghirlanda G, Bochicchio GB, Caputo S, Uccioli L, Rebuzzi AG (1985) Le catecolamine ematiche nella cirrosi epatica [Blood catecholamines in liver cirrhosis]. Minerva Med 76(41):1911–1915

CAS  PubMed  Google Scholar 

Darwish R, Elias AN, Vaziri ND, Pahl M, Powers D, Stokes JD (1984) Plasma and urinary catecholamines and their metabolites in chronic renal failure. Arch Intern Med 144(1):69–71

Article  CAS  PubMed  Google Scholar 

Beukers RJ, Booij J, Weisscher N, Zijlstra F, van Amelsvoort TAMJ, Tijssen MAJ (2008) Reduced striatal D2 receptor binding in myoclonus–dystonia. Eur J Nucl Med Mol Imaging 36:269–274

Article  PubMed  Google Scholar 

Chen YZ, Friedman JR, Chen DH, Chan GC, Bloss CS, Hisama FM, Topol SE, Carson AR, Pham PH, Bonkowski ES, Scott ER, Lee JK, Zhang G, Oliveira G, Xu J, Scott-Van Zeeland AA, Chen Q, Levy S, Topol EJ, Storm D, Swanson PD, Bird TD, Schork NJ, Raskind WH, Torkamani A (2014) Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia. Ann Neurol 75(4):542–549

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karimi M, Moerlein SM, Videen TO, Luedtke RR, Taylor M, Mach RH, Perlmutter JS (2010) Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect? Mov. Disord 26:100–106

Article  Google Scholar 

Nyberg P, Gottfries CG, Holmgren G, Persson S, Roos BE, Winblad B (1982) Advanced catecholaminergic disturbances in the brain in a case of Wilson’s disease. Acta Neurol Scand 65(1):71–75

Article  CAS  PubMed  Google Scholar 

Barthel H, Hermann W, Kluge R, Hesse S, Collingridge DR, Wagner A, Sabri O (2003) Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease. AJNR Am J Neuroradiol 24(2):234–238

PubMed  PubMed Central  Google Scholar 

Barbeau A, Friesen H (1970) Treatment of Wilson’s disease with L-dopa after failure with penicillamine. Lancet. 1:1180–1181

Article  CAS  PubMed  Google Scholar 

Berio A, Vento R, Di Stefano A (1973) Favorable results with an association of L-dopa and amantadine added to penicillamine in the treatment of Wilson’s disease. Minerva Pediatr. 25:807–813

CAS  PubMed  Google Scholar 

Gelmers HJ, Troost J, Willemse J (1973) Wilson’s disease: modification by L-dopa. Neuropediatriatrics 4:453–457

Article  CAS